• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Pre-autologous transplantation PET/CT using Deauville criteria is an independent predictor of progression in relapsed refractory classical Hodgkin lymphoma.

作者信息

Damlaj M, Ghazi S, Syed G, Pasha T, Gmati G, Salama H, Ali O, Abuelgasim K A, Al-Zahrani M, Hejazi A, Al Askar A

机构信息

Department of Oncology, Division of Hematology and HCT, King Abdulaziz Medical City, Riyadh, Saudi Arabia.

Department of Medical Imaging, King Abdulaziz Medical City, Riyadh, Saudi Arabia.

出版信息

Bone Marrow Transplant. 2017 Sep;52(9):1342-1344. doi: 10.1038/bmt.2017.143. Epub 2017 Jul 10.

DOI:10.1038/bmt.2017.143
PMID:28692029
Abstract
摘要

相似文献

1
Pre-autologous transplantation PET/CT using Deauville criteria is an independent predictor of progression in relapsed refractory classical Hodgkin lymphoma.采用多维尔标准的自体移植前PET/CT是复发难治性经典型霍奇金淋巴瘤病情进展的独立预测指标。
Bone Marrow Transplant. 2017 Sep;52(9):1342-1344. doi: 10.1038/bmt.2017.143. Epub 2017 Jul 10.
2
F-18 FDG-PET predicts outcomes for patients receiving total lymphoid irradiation and autologous blood stem-cell transplantation for relapsed and refractory Hodgkin lymphoma.18F-FDG-PET 预测复发和难治性霍奇金淋巴瘤患者接受全身淋巴照射和自体造血干细胞移植的预后。
Br J Haematol. 2014 Jun;165(6):793-800. doi: 10.1111/bjh.12824. Epub 2014 Mar 15.
3
Single or tandem autologous stem-cell transplantation for first-relapsed or refractory Hodgkin lymphoma: 10-year follow-up of the prospective H96 trial by the LYSA/SFGM-TC study group.单倍体或串联自体干细胞移植治疗首次复发或难治性霍奇金淋巴瘤：LYSA/SFGM-TC研究组前瞻性H96试验的10年随访
Haematologica. 2016 Apr;101(4):474-81. doi: 10.3324/haematol.2015.136408. Epub 2015 Dec 31.
4
A multi-institutional analysis of peritransplantation radiotherapy in patients with relapsed/refractory Hodgkin lymphoma undergoing autologous stem cell transplantation.对接受自体干细胞移植的复发/难治性霍奇金淋巴瘤患者移植前放疗的多机构分析。
Cancer. 2017 Apr 15;123(8):1363-1371. doi: 10.1002/cncr.30482. Epub 2016 Dec 16.
5
Nivolumab for the treatment of relapsed and refractory classical Hodgkin lymphoma after ASCT and in ASCT-naïve patients.纳武利尤单抗用于自体造血干细胞移植后复发及难治性经典型霍奇金淋巴瘤以及未接受过自体造血干细胞移植患者的治疗。
Leuk Lymphoma. 2019 Sep;60(9):2316-2319. doi: 10.1080/10428194.2019.1573368. Epub 2019 Feb 4.
6
[Treatment of patients with relapsed/refractory Hodgkin lymphoma].[复发/难治性霍奇金淋巴瘤患者的治疗]
Klin Onkol. 2011;24(2):121-5.
7
Tumor associated macrophages in relapsed and refractory Hodgkin lymphoma.复发难治性霍奇金淋巴瘤中的肿瘤相关巨噬细胞。
Leuk Res. 2013 Sep;37(9):1178-83. doi: 10.1016/j.leukres.2013.03.021. Epub 2013 May 21.
8
Pretransplant functional imaging and outcome in pediatric patients with relapsed/refractory Hodgkin lymphoma undergoing autologous transplantation.接受自体移植的复发/难治性霍奇金淋巴瘤儿科患者的移植前功能成像与预后
Pediatr Blood Cancer. 2018 Jan;65(1). doi: 10.1002/pbc.26707. Epub 2017 Jul 11.
9
Improved outcomes after autologous bone marrow transplantation for children with relapsed or refractory Hodgkin lymphoma: twenty years experience at a single institution.自体骨髓移植治疗复发或难治性霍奇金淋巴瘤患儿的疗效改善：单中心20年经验
Biol Blood Marrow Transplant. 2015 Feb;21(2):326-34. doi: 10.1016/j.bbmt.2014.10.020. Epub 2014 Oct 29.
10
PET positive progressive transformation of germinal centers masquerading as relapsed Hodgkin lymphoma post-autograft.
Leuk Lymphoma. 2006 Apr;47(4):764-5.

引用本文的文献

1
Real-world outcomes of brentuximab vedotin as consolidation therapy after autologous stem cell transplantation in relapsed/refractory Hodgkin lymphoma: A systematic review and meta-analysis.复发/难治性霍奇金淋巴瘤自体干细胞移植后使用本妥昔单抗进行巩固治疗的真实世界结果：一项系统评价和荟萃分析。
Bone Marrow Transplant. 2025 Apr 8. doi: 10.1038/s41409-025-02557-7.
2
Role of Radiomics-Based Baseline PET/CT Imaging in Lymphoma: Diagnosis, Prognosis, and Response Assessment.基于影像组学的基线 PET/CT 成像在淋巴瘤中的作用：诊断、预后和反应评估。
Mol Imaging Biol. 2022 Aug;24(4):537-549. doi: 10.1007/s11307-022-01703-7. Epub 2022 Jan 14.
3

本文引用的文献

1
Adapted Treatment Guided by Interim PET-CT Scan in Advanced Hodgkin's Lymphoma.基于中期PET-CT扫描指导的晚期霍奇金淋巴瘤适应性治疗
N Engl J Med. 2016 Jun 23;374(25):2419-29. doi: 10.1056/NEJMoa1510093.
2
Role of imaging in the staging and response assessment of lymphoma: consensus of the International Conference on Malignant Lymphomas Imaging Working Group.影像学在淋巴瘤分期及疗效评估中的作用：恶性淋巴瘤国际会议影像工作组共识
J Clin Oncol. 2014 Sep 20;32(27):3048-58. doi: 10.1200/JCO.2013.53.5229.
3
High-dose chemotherapy followed by autologous stem cell transplantation for patients with relapsed/refractory Hodgkin lymphoma.
Promising remissions in relapsed refractory classical Hodgkin lymphoma patients requiring multiple salvage regimens before transplantation in the brentuximab vedotin era.
在本妥昔单抗时代，复发难治性经典型霍奇金淋巴瘤患者在移植前需要多种挽救方案，仍有显著缓解情况。
Leuk Res Rep. 2021 Oct 21;16:100276. doi: 10.1016/j.lrr.2021.100276. eCollection 2021.
4
Chemoimmunotherapy with brentuximab vedotin combined with ifosfamide, gemcitabine, and vinorelbine is highly active in relapsed or refractory classical Hodgkin lymphoma.用本妥昔单抗联合异环磷酰胺、吉西他滨和长春瑞滨进行化学免疫疗法，对复发或难治性经典型霍奇金淋巴瘤具有高度活性。
Bone Marrow Transplant. 2019 Jul;54(7):1168-1172. doi: 10.1038/s41409-019-0454-z. Epub 2019 Jan 30.
复发/难治性霍奇金淋巴瘤患者接受大剂量化疗后进行自体干细胞移植。
Cochrane Database Syst Rev. 2013 Jun 20;2013(6):CD009411. doi: 10.1002/14651858.CD009411.pub2.
4
Positron emission tomographic scans in lymphoma: convention and controversy.正电子发射断层扫描在淋巴瘤中的应用：常规与争议。
Mayo Clin Proc. 2012 Jun;87(6):571-80. doi: 10.1016/j.mayocp.2012.03.006.
5
Positron emission tomography response at the time of autologous stem cell transplantation predicts outcome of patients with relapsed and/or refractory Hodgkin's lymphoma responding to prior salvage therapy.在接受先前挽救性治疗后缓解的复发和/或难治性霍奇金淋巴瘤患者中，自体干细胞移植时的正电子发射断层扫描反应可预测其结局。
Haematologica. 2012 Jul;97(7):1073-9. doi: 10.3324/haematol.2011.056051. Epub 2012 Jan 22.
6
Normalization of pre-ASCT, FDG-PET imaging with second-line, non-cross-resistant, chemotherapy programs improves event-free survival in patients with Hodgkin lymphoma.对于霍奇金淋巴瘤患者，ASCT 前通过二线、非交叉耐药、化疗方案进行 FDG-PET 显像规范化可改善无事件生存。
Blood. 2012 Feb 16;119(7):1665-70. doi: 10.1182/blood-2011-10-388058. Epub 2011 Dec 19.
7
Pre-transplant positron emission tomography in patients with relapsed Hodgkin lymphoma.移植前复发霍奇金淋巴瘤患者的正电子发射断层扫描。
Leuk Lymphoma. 2011 Sep;52(9):1668-74. doi: 10.3109/10428194.2011.573889. Epub 2011 Jun 23.
8
Prognostic significance of FDG-PET in relapsed or refractory classical Hodgkin lymphoma treated with standard salvage chemotherapy and autologous stem cell transplantation.标准挽救化疗和自体干细胞移植治疗复发或难治性经典霍奇金淋巴瘤中 FDG-PET 的预后意义。
Biol Blood Marrow Transplant. 2011 Nov;17(11):1646-52. doi: 10.1016/j.bbmt.2011.04.011. Epub 2011 May 3.
9
Concordance between four European centres of PET reporting criteria designed for use in multicentre trials in Hodgkin lymphoma.四项欧洲 PET 报告标准在霍奇金淋巴瘤多中心试验中的一致性。
Eur J Nucl Med Mol Imaging. 2010 Oct;37(10):1824-33. doi: 10.1007/s00259-010-1490-5. Epub 2010 May 27.
10
Pretransplant positive positron emission tomography/gallium scans predict poor outcome in patients with recurrent/refractory Hodgkin lymphoma.移植前正电子发射断层扫描/镓扫描结果呈阳性预示着复发/难治性霍奇金淋巴瘤患者的预后不良。
Cancer. 2007 Jun 15;109(12):2481-9. doi: 10.1002/cncr.22714.